bluuebunny/crossref_metadata_2025_split huggingface dataset:
Medical Implant Heavy Metal Contents and Effect on Patients
Authors: Latka Kajetan , Kolodziej Waldemar , Domisiewicz Kacper , Lasowy Piotr , Latka Dariusz 
Published: September 2024

Abstract
Advanced metal implants are used in modern medical practice and significantly improve clinical prognosis and quality of life; however, the potential health risks caused by the release of heavy metal ions make further research in this area relevant. The aim of this study is to analyze current scientific sources on the impact of heavy metals released from metal biomedical implants on patients’ health, focusing on the clinical manifestations of these complications, the structure and characteristics of different metal implants, and the possibilities of modifying them. The following scientific methods were used in the study: analysis and synthesis, the method of analogy, induction, abstraction, and the bibliographic method. The study revealed significant health risks of heavy metal ions, such as allergic reactions, toxic complications, carcinogenesis, and systemic effects, including neurological and cardiovascular problems. Innovative modification methods, including surface treatments, nanotechnology, and the development of bio-soluble materials, showed potential to reduce these risks. However, the long-term effects of these modifications remain poorly understood and require further investigation. Heavy metal ions from biomedical implants pose significant health risks. Effective management and reduction of these risks require continuous monitoring, development of new materials, and advanced modification techniques. Further research is essential to understand the long-term effects of metal implants and to develop strategies to ensure patient safety and improve implant efficacy.
Mocetinostat as a Novel Selective Histone Deacetylase Inhibitor in the Promotion of Apoptosis in glioblastoma Cell Line C6 and T98G
Authors: Khathayer Firas , Mikael Mohammad Hussein 
Published: September 2024

Abstract

Background:
Histone deacetylase (HDAC) enzymes play a crucial role in regulating gene expression and epigenetic alterations in cancer cells. Mocetinostat (MGCD0103) is a novel, isotype-selective HDAC inhibitor that targets Class I (HDAC1, 2, 3, and 8) and Class IV (HDAC11) enzymes. It has been approved for the use in phase II trials for Hodgkin’s lymphoma.

Methods:
In this study, the glioblastoma cell (GBM) lines T98G and C6 were treated with different concentrations of MGCD0103 (0.0, 0.5, 1.0, 1.5, 2.0, and 2.5 μM). Western blot analysis was used to evaluate protein expression and flow cytometry was employed to assess apoptosis.

Results:
The results demonstrated that MGCD0103 exerts multiple anti-cancer activities in GBMs. MGCD0103 modulated key signaling pathways, including inhibition of the Phosphatidylinositol 3- kinase (PI3K)/protein kinase B mechanism pathway and suppression of HDAC1 enzyme activity. High doses of MGCD0103 significantly induced apoptosis and suppressed cell proliferation by upregulating the pro-apoptotic protein Bcl-2-associated protein x and downregulating the anti-apoptotic proteins BH3 Interacting Domain Death Agonist and B-cell leukemia/lymphoma 2 protein. In addition, MGCD0103 treatment upregulated the expression of the tumor-suppressor gene and downregulated the E2F1 transcription factor. Furthermore, MGCD0103 facilitated cell differentiation by activating the glial fibrillary acidic protein Glial Fibrillary acidic protein (GFAP) as distinguish marker of astrocytes, and suppressing the undifferentiation markers Inhibitor of Deoxyribonucleic acid binding 2 and N-Myc proto-oncogene protein.

Conclusion:
This research suggests that MGCD0103 is a promising drug for inhibiting the proliferation, invasion, and migration of GBMs. The findings also provide new insights into the ability of MGCD0103 to induce differentiation in GBMs. Overall, these results indicate that MGCD0103 could be a potent therapeutic agent for the target of glioblastoma.
A Study on the Conventional and Molecular Approaches for the Identification of Pseudomonas aeruginosa and Its Antimicrobial Susceptibility Pattern in Diabetic Foot Ulcers
Authors: Nazer Madiha Abdul Majeed Abdul , Kuthalaramalingam Sethumadhavan , Sambandam Ravikumar , Ragunathan Latha , Panneerselvam Bharathi , Ilango Deepika 
Published: September 2024

Abstract

Background:
Diabetes mellitus is a major health concern, and the development of foot ulcers is a serious complication. Pseudomonas aeruginosa is a common causative pathogen in diabetic foot infections, which can lead to delayed wound healing and increased morbidity. This study aims to compare the diagnostic performance of conventional microbiological methods and molecular techniques (polymerase chain reaction [PCR]) for the identification of P. aeruginosa in diabetic foot ulcers and to evaluate its antimicrobial susceptibility pattern.

Methods:
This cross-sectional study was conducted in a tertiary care hospital, involving 134 patients with diabetic foot ulcers. Samples were collected and conventional culture methods were used to identify the pathogens and perform antimicrobial susceptibility testing. In addition, a single-step DNA extraction method (AmpReady) and conventional PCR were utilized for the molecular identification of P. aeruginosa.

Results:
The study found that the PCR technique was more efficient than conventional culture methods in identifying P. aeruginosa, with 44% detection by PCR compared to 14% by conventional culture. According to the antimicrobial susceptibility testing, co-trimoxazole was the most resistant drug against P. aeruginosa, while amikacin was the most sensitive.

Conclusion:
The study highlights the importance of using molecular techniques like PCR for accurate and faster identification of pathogens like P. aeruginosa in diabetic foot ulcers, which is crucial for appropriate antibiotic treatment and management of these infections. The findings contribute to a better understanding of the diagnostic validity and antimicrobial susceptibility patterns of P. aeruginosa in diabetic foot ulcers, which can aid in improving clinical management and outcomes for these patients.
The Complete Chloroplast Genome of Syzygium syzygioides (Myrtaceae: Myrtales) and Phylogenetic Analysis
Authors: Huynh Thu-Thao Thi , Quang Minh Trong , Nguyen Hoang Danh 
Published: September 2024

Abstract

Background:

Syzygium syzygioides (Miq.) Merr. and L. M. Perry is a common medicinal plant species known for its biologically active compounds. However, the chloroplast (cp) genome of S. syzygioides has not been previously reported. This study aimed to determine the complete cp genome sequence of S. syzygioides and investigate its phylogenetic relationships within the Syzygium genus.

Methods:
Leaf samples of S. syzygioides were collected from Vietnam, and the complete cp genome was sequenced and assembled. Phylogenetic analyses were then conducted to examine the evolutionary relationships between S. syzygioides and other Syzygium species.

Results:
The cp genome of S. syzygioides was found to be 158,172 base pairs in length, with a GC content of 37.0%. Phylogenetic reconstruction based on the cp genome data revealed that S. syzygioides is closely related to 10 other Syzygium species, including Syzygium buettnerianum, Syzygium bamagense, Syzygium grande, Syzygium megacarpum, Syzygium glomeratum, Syzygium claviflorum, Syzygium tsoongii, Syzygium fluviatile, Syzygium buxifolium, and Syzygium grijsii.

Conclusions:
This study provides the first report of the complete cp genome sequence of S. syzygioides, a medicinally important plant species in the Myrtaceae family. The phylogenetic analysis using the cp genome data sheds light on the evolutionary relationships within the Syzygium genus, which is the largest genus in the Myrtaceae. The new molecular data generated in this study can be used for the molecular identification and further phylogenetic investigations of Syzygium species, contributing to a better understanding of the diversity and evolutionary history of this economically and ecologically significant plant group.
Molecular Detection of Chlamydia pneumoniae, Haemophilus influenza, and Streptococcus pneumoniae and Expression of miR-146, miR-16, and miR-221 in Patients with Chronic Obstructive Pulmonary Diseases
Authors: Moattar Husseini Neda , Mohamadnia Abdolreza , Hosseini Farzaneh , Bahrami Naghmeh 
Published: September 2024

Abstract

Background:
Chronic obstructive pulmonary disease (COPD) is a debilitating respiratory condition characterized by persistent airflow limitation and chronic inflammation. Microbial infections and dysregulated microribonucleic acid (miRNA) expression have been implicated in COPD pathogenesis. This study aimed to investigate the molecular detection of three respiratory pathogens, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae, in the respiratory secretions of COPD patients. In addition, it evaluated the expression levels of miR-146, miR-16, and miR-221 in the peripheral blood of COPD patients.

Methods:
Peripheral blood and respiratory secretions were collected from 40 healthy individuals and 40 COPD patients. The messenger ribonucleic acid expression levels of miR-146, miR-16, and miR-221 were determined using real-time polymerase chain reaction. Statistical analyses, including t-test, binomial test, and Pearson correlation, were performed.

Results:

H. influenzae, S. pneumoniae, and C. pneumoniae were detected in the sputum of 12.5%, 17.5%, and 7.5% of COPD patients, respectively. The expression of miR-146, miR-221, and miR-16 was observed in 65%, 15%, and 85% of COPD patients, respectively, compared to 13%, 80%, and 15% of healthy subjects. While miR-221 was downregulated in COPD patients, miR-16 and miR-146 were upregulated. No significant differences were found in the expression of these miRNAs between infected and noninfected COPD patients.

Conclusion:
The molecular detection of respiratory pathogens and the expression profiles of miR-146, miR-16, and miR-221 in COPD patients may have potential diagnostic value. Further research is needed to elucidate the role of these markers in COPD pathogenesis.
Characterization of QuantiFERON Severe Acute Respiratory Syndrome Coronavirus 2 and Anti-severe Acute Respiratory Syndrome Coronavirus 2 Nucleocapsid and S1 Spike Protein Antibodies in Vaccinated and Unvaccinated Coronavirus Disease 2019 Patients
Authors: Mortaz Esmaeil , Roofchayee Neda Dalil , Jamaati Hamidreza , Tabarsi Payam , Ahmadi Shahrzad , Shahi Heshmat , Varahram Mohammad , Mogadam Kimia Behzad , Sajadi Mohammad M. , Adcock Ian M. 
Published: September 2024

Abstract

Background:
Coronavirus disease 2019 (COVID-19) vaccination has been shown to elicit both humoral (antibody) and cell-mediated (T-cell) immune responses. This study aimed to characterize and compare the QuantiFERON severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and anti-SARS-CoV-2 antibody responses in vaccinated and unvaccinated COVID-19 patients, as well as vaccinated healthy controls (HCs).

Methods:
A total of 96 COVID-19 patients (68 vaccinated with Sinopharm and 15 with AstraZeneca), 13 unvaccinated COVID-19 patients, and 16 vaccinated HCs (8 Sinopharm and 8 AstraZeneca) were included. Serum antibodies against the SARS-CoV-2 spike (S1) protein and nucleocapsid (N) protein were measured by enzyme-linked immunosorbent assay. T-cell responses were evaluated using the QuantiFERON assay against three SARS-CoV-2 viral antigens (Ag1, Ag2, and Ag3).

Results:
There were no significant differences in S1 antibody levels between COVID-19 patients (vaccinated or unvaccinated) and HCs. However, 100% of unvaccinated COVID-19 patients had anti-N antibodies, which was significantly higher than the AstraZeneca-vaccinated group. T-cell responses did not differ significantly between vaccinated and unvaccinated patients or between vaccinated patients and HCs. Vaccination with Sinopharm induced higher levels of total N antibodies and greater interferon-gamma release against the viral antigens compared to the other groups.

Conclusions:
Vaccination, especially with Sinopharm, induced robust humoral (N antibodies) and cellular (T-cell) immune responses in COVID-19 patients. The findings highlight the importance of vaccination in eliciting a comprehensive immune response against SARS-CoV-2, even in the context of prior infection.
Agreement between Phenotypically Detected Linezolid Resistance and Mutations in rrl and rplC Genes of Mycobacterium tuberculosis Isolates Using Nanopore Sequencing
Authors: Sengupta Senjuti , Jain Parul , Ratnam Rashmi , Pandey Bhoopendra Kumar , Singh Urmila , Kumar Vijay , Paliwal Ashutosh , Jain Amita 
Published: September 2024

Background:
Phenotypic drug susceptibility testing (DST) is considered the gold standard for detecting linezolid (LZD) resistance in Mycobacterium tuberculosis (MTB), but it is time-consuming. Nanopore sequencing offers a potentially faster alternative approach. This study evaluated the agreement between phenotypically detected LZD resistance and mutations in the rrl and rplC genes of MTB isolates using nanopore sequencing.

Methods:
Consecutive drug-resistant MTB isolates from pulmonary samples collected in 2021 underwent liquid culture (LC) DST for LZD. All resistant isolates and an equal number of susceptible isolates were subjected to targeted sequencing of the rrl and rplC genes using nanopore technology.

Results:
Sequencing identified a C154R mutation in the rplC gene in only one LZD-resistant isolate. No mutations were detected in the rrl gene. The agreement between sequencing and LC-DST for detecting LZD resistance was poor (Cohen’s kappa: 0.03571, 95% confidence interval [CI]: −0.034–0.105). Additionally, no significant association was found between LZD resistance and clinical or microbiological outcomes at 6-month follow-up.

Conclusion:
This study revealed a considerable discrepancy between phenotypic and genotypic detection of LZD resistance in MTB. Further research is needed to better understand the genetic mechanisms underlying LZD resistance and to develop reliable molecular diagnostics for rapid resistance detection.
Diagnostic Accuracy of FluoroCycler XT MTBDR Assay for Detection of Rifampicin and Isoniazid-resistant Mycobacteria tuberculosis in Clinical Isolates from Kenya
Authors: Mwangi Zakayo Maingi , Ireri Samson , Opwaka Haron , Otieno Leon , Simam Joan , Onyambu Frank Gekara , Mukiri Nellie 
Published: September 2024

Background:
Drug-resistant tuberculosis (DR-TB) poses a major global challenge to public health and therapeutics. It is an emerging global concern associated with increased morbidity and mortality mostly seen in the low- and middle-income countries. Molecular techniques are highly sensitive and offer timely and accurate results for TB drug resistance testing, thereby positively influencing patient management plan.

Methods:
The study was carried out at the National Tuberculosis Reference Laboratory (NTRL) in Kenya in the period between January and October 2022. A total of 243 Mycobacterium tuberculosis (M.tb) clinical isolates were included in the study. These isolates comprised of 50 isolates with mutations in rpoB, 51 isolates with katG mutations, 51 isolates with mutations in inhA, and 91 M.tb isolates lacking mutations in these genes based on Genotype MTBDRplus results. DNA from the isolates was extracted using the FluoroLyse extraction kit. Real-time polymerase chain reaction targeting the rpoB, InhA, and katG genes was performed using the FluoroType MTBDR amplification mix. Isolates with discordant results between Genotype MTBDRplus and FluoroCycler® MTBDR assays underwent targeted sequencing for the respective genes, then, sequences were analyzed for mutations using Geneious version 11.0 software.

Results:
The sensitivity of the Fluorocycler XT MTBDR assay for the detection of mutations that confer drug resistance was 86% (95% confidence interval [CI] 73.0–94.0) for rpoB, 96% (95% CI 87–100) for katG and 92% (95% CI 81–98) for inhA. The assay’s specificity was 97% (95% CI 93–99) for rpoB, 98% (95% CI 96–100) for katG, and 97% (95% CI 93–99) for inhA.

Conclusion:
The diagnostic accuracy of FluoroType MTBDR for the detection of mutations conferring resistance to rifampicin and isoniazid was high compared with that of Genotype MTBDRplus and demonstrates its suitability as a replacement assay for Genotype MTBDRplus.
Application of electrospray triple quadrupole mass spectrometry in assessing thalassemia in a population
Authors: Putchen Deepalakshmi D. , Nambiar Athira , Bijur Ashwini , Amirtharaj Nelson , Ramaprasad Sujay 
Published: September 2024

ABSTRACT

Introduction:
Thalassemia is widely prevalent in Asian countries and the Middle East region of the world. While the prevalence of α thal is around 5-20% in the population, the incidence of β thal is around 3-4%. The available data on thalassemia in Indians is based on chromatographic or electrophoretic techniques. The present study demonstrates the utility of mass spectrometry in detecting thalassemia in a small, healthy population from Tiptur, Karnataka.

Materials and Methods:
The study included a population of 315 individuals, spanning both children and adults, with ages ranging from 4 to 76 years. EDTA whole blood was collected after obtaining their written consent. The intensities of various globin chains were measured using a triple quadrupole mass spectrometer. The ratio of the peak areas of globin chains (α/β, δ/β (%)) served as biomarkers to detect thalassemia. Thirty random samples of α thalassemia were analyzed using GapPCR.

Results:
The prevalence of a thal is 21.65% (68/314) based on α/β (< =0.8) and the prevalence of β thal is 3.8% (12/314) based on δ/β (%) (> =11.0). GapPCR detected three heteromutants of α deletion, one mutation in the HBA1 gene, and one a triplication (16.7%, 5/30). One sample was excluded from the analysis due to the presence of a variant.

Conclusion:
The utility of mass spectrometry for screening thalassemia in a population is demonstrated. The higher occurrence of α-thalassemia in the studied population underscores the importance of screening for thalassemia in regions with reportedly high prevalence rates.
The BCOR-rearranged sarcoma involving the lung: Diagnosis with clinical outcome and literature review
Authors: Gupta Rakesh K. , Rekhi Bharat , Sharma Mehar C. , Ganga Ranganath , Ravina Mudalsha , Kumar Amit , Sahu Dibakar 
Published: September 2024

ABSTRACT

BCOR-rearranged sarcomas (BRS) constitute relatively newly described sarcomas, which, within the musculoskeletal sites, usually occur in the bones, followed by soft tissues. Primary BRS involving the visceral organs is very rare, and only a single case is reported in the lung. These tumors share overlapping morphological and immunohistochemical (IHC) features with other neoplasms, such as synovial sarcoma, Ewing sarcoma, as well as carcinosarcoma, the latter especially when occurring in the visceral organs. BCOR immunostaining is useful in triaging a tumor for molecular diagnosis, which constitutes the “essential” diagnostic criterion for these tumors. To report an extremely rare case of a BRS, confirmed by BCOR-rearrangement by fluorescence in situ hybridization (FISH), primarily occurring in the lung, emphasizing the diagnostic approach and management, along with review of literature. An18-year-old boy presented with complaints of left-sided chest pain, along with cough, fever, loss of appetite, and weight. On radio imaging, there was a complete collapse of the left lower lobe of lung with moderate pleural effusion. The biopsy showed a biphasic tumor comprising primitive round cells admixed with spindle cells. Immunohistochemically, the tumor cells were positive for BCOR, TLE1, and p53. FISH showed BCOR gene rearrangement. A diagnosis of primary BRS of lung was offered. The patient had a favorable response to the chemotherapy regime. BRS is an ultra-rare tumor, which rarely involves visceral organs. The lung is an exceptionally rare site, with only single reported case previously. An exact confirmation by molecular testing has treatment-associated implications. A review of similar reported cases is presented herewith.
An insight into the landscape of a rare tumor-persistent Mullerian duct syndrome with testicular seminoma
Authors: Sahoo Nibedita , Reddy Abhijna , Khuntia Manoranjan 
Published: September 2024

ABSTRACT
Persistent Mullerian duct syndrome (PMDS) is a rare form of internal male pseudohermaphroditism in phenotypically males with 46 XY karyotype. The syndrome is caused by insufficient amount of Mullerian-inhibiting substance (MIS) or due to insensitivity of the target organ to MIS. Till date, less than 300 cases of PMDS are described in English literature, and the association of testicular tumor is still rarer. We report a case of seminoma of testis with PMDS in a 22-year male who reported with intermittent pain, fullness, and dragging sensation over right-side lower abdomen for 4 years. The radiological impression was testicular mass arising from undescended testis with persistent Mullerian duct structures. Histopathology and immunohistochemistry confirmed the diagnosis. Association of undescended testis increases the likelihood of developing testicular tumor in PMDS. Clinicians and pathologists should be aware of the rare entity while dealing with the cryptorchidism with inguinal hernia, and necessary management should be done to reduce the complications.
Impaired Glucose Homeostasis Accompanies Cellular Changes in Endocrine Pancreas after Atorvastatin Administration
Authors: Abdel-Hamid Ahmed A. M. , Firgany Alaa El-Din L. 
Published: September 2024

Abstract
Atorvastatin (ATOR) has been reported to increase the risk for diabetes mellitus. Therefore, in the current study, we focused on studying the effect of ATOR on the structure of islets of Langerhans including their various cellular components as well as on glucose homeostasis. We detected a statistically significant increase (P < 0.05) in β-cell mass and percentage with a significant decrease in α-cell area and percentage in animals that received ATOR compared to control ones. In addition, a statistically significant increase (P < 0.05) in the β-cell proliferation was observed in the ATOR group with negligible change in expression of inflammatory cytokines of the islets. A significant downregulation in apoptosis alongside a significant upregulation in anti-apoptosis were detected in islets of animals treated with ATOR. Moreover, there was a significant impairment in various parameters of glucose homeostasis in the ATOR-treated group. Therefore, ATOR may induce insulin resistance-like state that was demarcated at cellular as well as at biochemical levels with little or no inflammatory response.
Reliability of YouTube videos on the management of orthodontic emergencies during COVID-19 pandemic: A quantitative and qualitative analysis
Authors: Hakami Zaki , Vishwanathaiah Satish , Marghalani Hussain Y. A. , Bokhari Ahmed M. , Alrwuili Mohammad Raji , Barashid Abdulaziz Abdullah S. , Sawadi Mohammad , Maganur Prabhadevi C. 
Published: September 2024

OBJECTIVES:
To assess the content of YouTube videos on the management of orthodontic emergencies during the COVID-19 pandemic.

MATERIALS AND METHODS:
YouTube was systematically searched using the keywords “orthodontic emergency,” “orthodontic homecare,” “braces emergency,” and “braces homecare.” The first 100 videos for each keyword were assessed. The upload source, number of views, likes and dislikes, duration, and global quality score were extracted. Home and clinical advice reliability was evaluated using the reliability score (DISCERN) according to the COVID-19 orthodontic emergencies protocol published by the British Orthodontic Society.

RESULTS:
The majority of the videos were found to be poor quality. Home care advice showed higher reliability than clinical advice. Orthodontic emergency videos uploaded by healthcare professionals had higher reliability.

CONCLUSION:
Many types of orthodontic emergencies have received little attention on YouTube, and more useful and reliable educational videos should be uploaded in the event of future pandemics.